Capital International Investors Elanco Animal Health Inc Transaction History

Capital International Investors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$18.94 - $24.93 $28.4 Million - $37.4 Million	-1,501,355 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$31.11 - $34.79 $24.6 Million - $27.5 Million	-789,745 Reduced 34.47%	1,501,355 $50.7 Million
Q1 2019 May 15, 2019	BUY	$29.0 - $32.83 $20.1 Million - $22.7 Million	692,490 Added 43.32%	2,291,100 $73.5 Million
Q4 2018 Feb 14, 2019	BUY	$29.63 - $34.5 $4.29 Million - $4.99 Million	144,771 Added 9.96%	1,598,610 $50.4 Million
Q3 2018 Nov 14, 2018	BUY	$34.1 - $36.19 $49.6 Million - $52.6 Million	1,453,839 New	1,453,839 $50.7 Million

438

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $6.63B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Capital International Investors, based on Form 13F filings with the SEC.

Stay updated on Capital International Investors with notifications on news.